Other OTC - Delayed Quote USD

Pharma Mar, S.A. (PHMMF)

26.85 0.00 (0.00%)
At close: April 15 at 12:19 PM EDT
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
162,140.00
158,153.00
196,343.00
229,831.00
269,961.00
Cost of Revenue
9,249.00
9,613.00
13,639.00
16,437.00
13,718.00
Gross Profit
152,891.00
148,540.00
182,704.00
213,394.00
256,243.00
Operating Expense
158,667.00
152,638.00
138,269.00
121,043.00
100,032.00
Operating Income
-5,776.00
-4,098.00
44,435.00
92,351.00
156,211.00
Net Non Operating Interest Income Expense
3,861.00
1,687.00
-1,501.00
-3,003.00
-2,788.00
Pretax Income
-3,176.00
-3,623.00
43,790.00
95,129.00
145,606.00
Tax Provision
-5,202.00
-4,760.00
-5,566.00
2,270.00
8,344.00
Net Income Common Stockholders
2,026.00
1,137.00
49,356.00
92,859.00
137,262.00
Diluted NI Available to Com Stockholders
2,026.00
1,137.00
49,356.00
92,859.00
137,262.00
Basic EPS
0.11
0.06
2.73
5.14
7.50
Diluted EPS
0.11
0.06
2.73
5.13
7.50
Basic Average Shares
17,507.86
17,900.00
18,050.00
18,070.00
18,293.00
Diluted Average Shares
17,507.86
17,916.00
18,063.00
18,085.00
18,325.00
Total Operating Income as Reported
-5,554.00
-3,827.00
44,071.00
92,447.00
155,944.00
Rent Expense Supplemental
--
1,646.00
1,675.00
--
--
Total Expenses
167,916.00
162,251.00
151,908.00
137,480.00
113,750.00
Net Income from Continuing & Discontinued Operation
2,026.00
1,137.00
49,356.00
92,859.00
137,262.00
Normalized Income
1,772.20
783.00
51,045.00
92,754.55
137,513.70
Interest Income
-58.00
4,103.00
875.00
370.00
336.00
Interest Expense
4,542.00
2,416.00
2,376.00
3,373.00
3,124.00
Net Interest Income
3,861.00
1,687.00
-1,501.00
-3,003.00
-2,788.00
EBIT
-2,965.00
-1,207.00
46,166.00
98,502.00
148,730.00
EBITDA
3,002.00
4,549.00
52,066.00
104,085.00
155,941.00
Reconciled Cost of Revenue
9,249.00
9,613.00
13,639.00
16,437.00
13,718.00
Reconciled Depreciation
5,967.00
5,756.00
5,900.00
5,583.00
7,211.00
Net Income from Continuing Operation Net Minority Interest
2,026.00
1,137.00
49,356.00
92,859.00
137,262.00
Total Unusual Items Excluding Goodwill
423.00
472.00
-2,252.00
107.00
-267.00
Total Unusual Items
423.00
472.00
-2,252.00
107.00
-267.00
Normalized EBITDA
2,579.00
4,077.00
54,318.00
103,978.00
156,208.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
169.20
118.00
-563.00
2.55
-15.30
12/31/2020 - 2/23/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade